PYY plays a key role in the resolution of diabetes following bariatric surgery in humans
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Bariatric surgery leads to early and long-lasting remission of type 2 diabetes (T2D). However, the mechanisms behind this phenomenon remain unclear. Among several factors, gut hormones are thought to be crucial mediators of this effect. Unlike GLP-1, the role of the hormone peptide tyrosine tyrosine (PYY) in bariatric surgery in humans has been limited to appetite regulation and its impact on pancreatic islet secretory function and glucose metabolism remains under-studied. METHODS: Changes in PYY concentrations were examined in obese patients after bariatric surgery and compared to healthy controls. Human pancreatic islet function was tested upon treatment with sera from patients before and after the surgery, in presence or absence of PYY. Alterations in intra-islet PYY release and insulin secretion were analysed after stimulation with short chain fatty acids (SCFAs), bile acids and the cytokine IL-22. FINDINGS: We demonstrate that PYY is a key effector of the early recovery of impaired glucose-mediated insulin and glucagon secretion in bariatric surgery. We establish that the short chain fatty acid propionate and bile acids, which are elevated after surgery, can trigger PYY release not only from enteroendocrine cells but also from human pancreatic islets. In addition, we identify IL-22 as a new factor which is modulated by bariatric surgery in humans and which directly regulates PYY expression and release. INTERPRETATION: This study shows that some major metabolic benefits of bariatric surgery can be emulated ex vivo. Our findings are expected to have a direct impact on the development of new non-surgical therapy for T2D correction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551 · cited 1×
“Bariatric surgery results in rapid and durable reversal of type 2 diabetes (T2D) and associated metabolic bene fi ts in man [1].”
Inhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604 · cited 4×
“Serum total PYY levels were measured in obese patients before (mean ± SEM; BMI 47 ± 8.4) and six months after either gastric bypass or sleeve gastrectomy (SG; mean ± SEM; BMI 37.5 ± 7.4; p b 0.0001) and compared with healthy volunteers (mean ± SEM; BMI 22.24 ± 2.1) (Fig.”
InfluentialChambers, E. S., Viardot, A., Psichas, A., Morrison, D. J., Murphy, K. G., Zac-Varghese, S. E. K., MacDougall, K., Preston, T., Tedford, C., Finlayson, G. S., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307913 · Cited by 1,424
Chronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186 · cited 8×
“These latter reports are consistent with our fi ndings in which IL-6 and IL-23 levels were unaffected by bariatric surgery in humans.”
InfluentialConserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity
Liou, A. P., Paziuk, M., Luevano, J.-M., Machineni, S., Turnbaugh, P. J., & Kaplan, L. M. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005687 · Cited by 1,007 · cited 2×
“Bacterial-derived metabolites, such as short chain fatty acids increase in rodents and man following bariatric surgery [29,30] and can directly modulate PYY secretion from L-cells [31,32].”
Tremaroli, V., Karlsson, F., Werling, M., Ståhlman, M., Kovatcheva-Datchary, P., Olbers, T., Fändriks, L., le Roux, C. W., Nielsen, J., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.009 · Cited by 757
Glucose Sensing in L Cells: A Primary Cell Study
Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733 · cited 1×
“Colonic primary cultures were prepared as previously described [26,27] Colon and rectum were quickly isolated from mice sacri fi ced by cervical dislocation, washed thoroughly with PBS and cleaned of their outer muscle layer.”
Self-citationPatti, M., Houten, S. M., Bianco, A. C., Bernier, R., Larsen, P. R., Holst, J. J., Badman, M. K., Maratos‐Flier, E., Mun, E. C., Pihlajamaki, J., et al. (2009) · Obesity · doi:10.1038/oby.2009.102 · Cited by 591 · cited 1×
“In patients, fasting and postprandial bile acid concentrations rise following RYGB, while conflicting results have been reported after SG [34,46].”
Zhang, Q., Ramracheya, R., Lahmann, C., Tarasov, A., Bengtsson, M., Braha, O., Braun, M., Brereton, M., Collins, S., Galvanovskis, J., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.014 · Cited by 225
Self-citationKumar, D. P., Rajagopal, S., Mahavadi, S., Mirshahi, F., Grider, J. R., Murthy, K. S., & Sanyal, A. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.104 · Cited by 206
Inflammatory markers and bariatric surgery: a meta-analysis
Rao, S. R. (2012) · Inflammation Research · doi:10.1007/s00011-012-0473-3 · Cited by 162
Bile acids and bariatric surgery
Albaugh, V. L., Banan, B., Ajouz, H., Abumrad, N. N., & Flynn, C. R. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.001 · Cited by 148 · cited 2×
“In patients, fasting and postprandial bile acid concentrations rise following RYGB, while con fl icting results have been reported after SG [34,46].”
Olofsson, C. S., Salehi, A., Holm, C., & Rorsman, P. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.066258 · Cited by 88 · cited 1×
“Mouse islets were isolated by liberase (Sigma-Aldrich Ltd., Gilling-ham, UK) digestion as described previously [23].”
Self-citationHasib, A. (2020) · Clinical Medicine Insights: Endocrinology and Diabetes · doi:10.1177/1179551420905844 · Cited by 29
Research works printed but not linked: 39
- Holst, 2016, Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor, Surg Obes Relat Dis, 12, 1236, 10.1016/j.soard.2016.02.033 · DOI · Paper page
- Mokadem, 2014, Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency, Mol Metab, 3, 191, 10.1016/j.molmet.2013.11.010 · DOI · Paper page
- Wilson-Perez, 2013, Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency, Diabetes, 62, 2380, 10.2337/db12-1498 · DOI · Paper page
- Pournaras, 2010, The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study, Obes Surg, 20, 56, 10.1007/s11695-009-9989-1 · DOI
- Clements, 2004, Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus, Am Surg, 70, 1, 10.1177/000313480407000101 · DOI · Paper page
- Rubino, 2004, The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism, Ann Surg, 240, 236, 10.1097/01.sla.0000133117.12646.48 · DOI · Paper page
- Ramracheya, 2016, PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery, Cell Rep, 15, 944, 10.1016/j.celrep.2016.03.091 · DOI · Paper page
- Karamanakos, 2008, Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study, Ann Surg, 247, 401, 10.1097/SLA.0b013e318156f012 · DOI · Paper page
- Peterli, 2009, Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial, Ann Surg, 250, 234, 10.1097/SLA.0b013e3181ae32e3 · DOI · Paper page
- Papamargaritis, 2013, Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy, Surg Obes Relat Dis, 9, 192, 10.1016/j.soard.2012.08.007 · DOI
- Federico, 2016, Gastrointestinal hormones, intestinal microbiota and metabolic homeostasis in obese patients: effect of bariatric surgery, In Vivo, 30, 321
- Guida, 2018, Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY, Diabetes Obes Metab, 20, 571, 10.1111/dom.13113 · DOI
- Bhutta, 2015, Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats, PLoS One, 10, 10.1371/journal.pone.0122273 · DOI · Paper page
- Larraufie, 2017, TLR ligands and butyrate increase Pyy expression through two distinct but inter-regulated pathways, Cell Microbiol, 19, 10.1111/cmi.12648 · DOI · Paper page
- Viana, 2013, Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-alpha. Prospective clinical trial, Obes Surg, 23, 1252, 10.1007/s11695-013-0894-2 · DOI
- Miller, 2011, Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery, Surg Obes Relat Dis, 7, 618, 10.1016/j.soard.2011.03.006 · DOI · Paper page
- Wang, 2014, Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes, Nature, 514, 237, 10.1038/nature13564 · DOI · Paper page
- Hasnain, 2014, Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress, Nat Med, 20, 1417, 10.1038/nm.3705 · DOI · Paper page
- Lake, 1989, Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator, Diabetes, 38, 143, 10.2337/diab.38.1.S143 · DOI · Paper page
- Jorgensen, 2013, Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes, Diabetes, 62, 3044, 10.2337/db13-0022 · DOI · Paper page
- Psichas, 2017, Mixed primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells, JoVE, 122
- Ilhan, 2017, Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding, ISME J, 11, 2047, 10.1038/ismej.2017.71 · DOI · Paper page
- Psichas, 2015, The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents, Int J Obes (Lond), 7, 424, 10.1038/ijo.2014.153 · DOI · Paper page
- Pingitore, 2017, The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro, Diabetes Obes Metab, 19, 257, 10.1111/dom.12811 · DOI · Paper page
- Bala, 2014, Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-epsilon pathway and modulated by endogenous H2S, Front Physiol, 5, 420, 10.3389/fphys.2014.00420 · DOI · Paper page
- Sabat, 2015, Deciphering the role of interleukin-22 in metabolic alterations, Cell Biosci, 5, 68, 10.1186/s13578-015-0060-8 · DOI
- Shioya, 2008, Interleukin 22 receptor 1 expression in pancreas islets, Pancreas, 36, 197, 10.1097/MPA.0b013e3181594258 · DOI
- Murphy, 2016, Sleeve gastrectomy versus Roux-en-Y gastric bypass for type 2 diabetes and morbid obesity: double-blind randomised clinical trial protocol, BMJ Open, 6, 10.1136/bmjopen-2016-011416 · DOI
- Major, 2015, Changes in levels of selected incretins and appetite-controlling hormones following surgical treatment for morbid obesity, Wideochir Inne Tech Maloinwazyjne, 10, 458
- Nannipieri, 2013, Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones, J Clin Endocrinol Metab, 98, 4391, 10.1210/jc.2013-2538 · DOI · Paper page
- Guo, 2018, Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery, Eur J Endocrinol, 178, 43, 10.1530/EJE-17-0403 · DOI · Paper page
- Lin, 2012, Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms, PLoS One, 7, 10.1371/journal.pone.0035240 · DOI · Paper page
- Prawitt, 2011, Bile acid metabolism and the pathogenesis of type 2 diabetes, Curr Diab Rep, 11, 160, 10.1007/s11892-011-0187-x · DOI · Paper page
- Renga, 2010, The bile acid sensor FXR regulates insulin transcription and secretion, Biochim Biophys Acta, 1802, 363, 10.1016/j.bbadis.2010.01.002 · DOI · Paper page
- Richette, 2011, Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis, Ann Rheum Dis, 70, 139, 10.1136/ard.2010.134015 · DOI · Paper page
- Chacon, 2008, Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro, Int J Obes (Lond), 32, 1122, 10.1038/ijo.2008.40 · DOI
- Stolberg, 2018, Effects of gastric bypass surgery followed by supervised physical training on inflammation and endothelial function: a randomized controlled trial, Atherosclerosis, 273, 37, 10.1016/j.atherosclerosis.2018.04.002 · DOI · Paper page
- Yang L, Zhang Y, Wang L, Fan F, Zhu L, Li Z, et al. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J Hepatol 2010;53(2):339–47. · DOI · Paper page
- Nostedt, 2016, The effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease, Can J Gastroenterol Hepatol, 2016, 2059245, 10.1155/2016/2059245 · DOI
Cited by
Treatment of type 2 diabetes: challenges, hopes, and anticipated successes
Nauck, M. A., Wefers, J., & Meier, J. J. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00113-3 · Cited by 289
Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management
Marjot, T., Moolla, A., Cobbold, J. F., Hodson, L., & Tomlinson, J. W. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz009 · Cited by 228
Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes
Lafferty, R. A., Flatt, P. R., & Irwin, N. (2021) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000612 · Cited by 42
Appetite control: Hormones or diet strategies?
Freire, R. H., & Alvarez-Leite, J. I. (2020) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000675 · Cited by 37
“[30] 20 Healthy controls and 25 patients after bariatric surgery Evaluation 1-year post-RYGB or postSG PYY was 25% lower in obesity compared with control Following both RYGB and SG, serum PYY in obese patients increased to levels seen in normal-weight individuals”
BackgroundResultNovel GLP-1-based Medications for Type 2 Diabetes and Obesity
Son, J. W., le Roux, C. W., Blüher, M., Nauck, M. A., & Lim, S. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnaf036 · Cited by 40
Metadata
- Authors
- Guida, C., Stephen, S. D., Watson, M., Dempster, N., Larraufie, P., Marjot, T., Cargill, T., Rickers, L., Pavlides, M., Tomlinson, J., Cobbold, J. F. L., Zhao, C.-M., Chen, D., Gribble, F., Reimann, F., Gillies, R., Sgromo, B., Rorsman, P., Ryan, J. D., & Ramracheya, R. D.
- Venue
- EBioMedicine
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 40
- Pages
- 67-76
- ISSN
- 2352-3964 (ISSN-L)
- OpenAlex
- W2911185744
- Cited by
- 97
- References
- 15
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Novo Nordisk
- Norges Teknisk-Naturvitenskapelige Universitet
- Vetenskapsrådet
- National Institute for Health and Care Research
- European Association for the Study of the Liver
- St. Olavs Hospital Universitetssykehuset i Trondheim
- Diabetes UK
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.